Riskpilot← Back to searchSign inGet full accessSVELVIK LEGESENTER AS
ASActiveOrg 916845715Storgaten 94, 3060 SvelvikGeneral medical practice activities · NACE 8621Est. 20165 employees
Revenue 2024
NOK 4,7M
-5% vs 2023
EBITDA margin
11.5%
+784% vs 2023
Equity ratio
-244.2%
Financial strength
Net profit 2024
NOK 534K
+496% vs 2023
| Revenue | NOK 4,7M | -5% |
| EBITDA | NOK 538K | +784% |
| Net profit | NOK 534K | +496% |
| Total assets | NOK 133K | -55% |
| Equity | NOK -324K | +62% |
| Employees | 5 | — |
Legal name
SVELVIK LEGESENTER AS
Org number
916845715
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
4. mars 2016
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legepraksis og helsetjenester, formidling av slike tjenester samt forretningsdrift av enhver art, herunder agentur-, kommisjons- og engrosvirksomhet, konsulentvirksomhet, kjøp, salg og drift av faste eiendommer, finansformidling, idrettsmedisin og trenervirksomhet samt megling av sponsoravtaler, samt hva hermed står i forbindelse, herunder å delta i andre selskaper, innen- og utenlands med lignende forretningsvirksomhet som formål.
Address
Storgaten 94, 3060 Svelvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 978 | 4 218 | 4 067 | 4 936 | 4 671 |
| Staff expenses | −2 749 | −3 312 | −3 351 | −3 669 | −2 810 |
| EBITDA | −53 | −15 | −314 | −79 | 538 |
| Depreciation & amort. | −57 | −6 | −14 | −0 | −0 |
| EBIT | −110 | −21 | −328 | −79 | 538 |
| Net financials | −10 | −11 | −40 | −56 | 4 |
| Profit before tax | −120 | −32 | −367 | −135 | 542 |
| Tax | −17 | −0 | −0 | −0 | 9 |
| Net profit | −103 | −32 | −367 | −135 | 534 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 279 | 384 | 66 | 296 | 133 |
| Equity | −324 | −356 | −723 | −858 | −324 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 603 | 740 | 790 | 1 155 | 457 |
| Total debt | 603 | 740 | 790 | 1 155 | 457 |
EBITDA margin
11.5%
This company
15.8%
Market median
-27% vs market
20202024
Equity ratio
-244.2%
This company
38.2%
Market median
-739% vs market
20202024
Return on equity
53359400.0%
This company
18.4%
Market median
+289996639% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
35.16×
This company
1.12×
Market median
+3039% vs market
20202024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TS Chief Executive Officer | Chief Executive Officer | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SVELVIK LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tadeusz Stanislaw Tomala | Chief Executive Officer | 0 companies |